Real-World Experience Using Proton Versus Photon Craniospinal Irradiation for Leptomeningeal Disease
Practical Radiation Oncology · 2025-09 · 15 (5) · 472-480
DOI: 10.1016/j.prro.2025.03.015 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Practical Radiation Oncology, 2025-09. Verfasst von Kelsey M Frechette und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota. Electronic address: Frechette.Kelsey@mayo.edu. Hauptthemen laut MEDLINE: Craniospinal Irradiation, Proton Therapy, Photons, Meningeal Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
PURPOSE: Data demonstrate improved survival with proton craniospinal irradiation (CSI) over involved field radiation therapy for leptomeningeal disease (LMD). It is unknown how photon CSI compares in the treatment of LMD. We report our institution's real-world experience using proton versus photon CSI for LMD. METHODS AND MATERIALS: We performed a retrospective review of LMD patients treated with photon or proton CSI from January 2021 to February 2024. All histologies were included. Patient characteristics and complete blood counts were collected before and after CSI. The primary endpoint was serious cytopenia likely caused by CSI. The median overall survival was estimated using the Kaplan-Meier method. RESULTS: Thirty-six patients with LMD treated with CSI (27 proton and 9 photon) were included. Across all major cell lines (hemoglobin, platelets, leukocytes, neutrophils, and lymphocytes), the rate of serious (grade 3 or higher) cytopenia likely caused by CSI was not different between the proton and photon groups (p > .21). The median overall survival in the proton and photon groups was 3.0 months and 1.7 months, respectively (hazard ratio, 1.49; p = .47). CONCLUSIONS: In a single-institutional experience treating LMD, acute cytopenias likely caused by CSI were not different between proton and photon CSI across all major cell lines. Survival was also similar between modalities; therefore, photon CSI may be a safe, efficacious option for LMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota. Electronic address: Frechette.Kelsey@mayo.edu.
- Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota.
- Department of Biostatistics and Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
- Department of Neurology, Mayo Clinic, Rochester, Minnesota.
Zitieren
APA
Frechette, K. M., Meyer, A. F., Leier, S. B., Harmsen, W. S., Pulsipher, S. D., Matysiak, W., Bradley, T. B., Sener, U. T., Webb, L. M., Routman, D. M., Yan, E., Laack, N. N., Brown, P. D., Lehrer, E. J., Breen, W. G., Kowalchuk, R. O., & Mahajan, A. (2025). Real-World Experience Using Proton Versus Photon Craniospinal Irradiation for Leptomeningeal Disease. Practical Radiation Oncology, 15(5), 472-480. https://doi.org/10.1016/j.prro.2025.03.015
Vancouver
Frechette KM, Meyer AF, Leier SB, Harmsen WS, Pulsipher SD, Matysiak W, et al. Real-World Experience Using Proton Versus Photon Craniospinal Irradiation for Leptomeningeal Disease. Practical Radiation Oncology. 2025;15(5):472-480. doi:10.1016/j.prro.2025.03.015
BibTeX
@article{Frechette2025,
author = {Frechette, Kelsey M and Meyer, Amanda F and Leier, Sara B and Harmsen, William S and Pulsipher, Sydney D and Matysiak, Witold and Bradley, Thomas B and Sener, Ugur T and Webb, Lauren M and Routman, David M and Yan, Elizabeth and Laack, Nadia N and Brown, Paul D and Lehrer, Eric J and Breen, William G and Kowalchuk, Roman O and Mahajan, Anita},
title = {Real-World Experience Using Proton Versus Photon Craniospinal Irradiation for Leptomeningeal Disease},
journal = {Practical Radiation Oncology},
year = {2025},
volume = {15},
number = {5},
pages = {472--480},
doi = {10.1016/j.prro.2025.03.015}
}
EUVIMED